The 3 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 18.00, with a high estimate of 25.00 and a low estimate of 16.00. The median estimate represents a +634.69% increase from the last price of 2.45.
The current consensus among 3 polled investment analysts is to Buy stock in Mustang Bio Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.58
Reporting Date Nov 14
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.